Nuclear Therapeutics
Delivering state-of-the-art Radioligand Therapy to prostate cancer patients through trusted partnerships with urology groups.
Dr. Barbara J. Cook, M.D., is a board-certified Nuclear Medicine specialist, providing targeted, patient-centered care by administering Pluvicto (Lutetium-177 vipivotide tetraxetan PSMA) and Xofigo (Radium-223) therapies within Urology practices.
Our Services
Authorized Treatments
Dr. Barbara Cook is an Authorized User (AU) for advanced radiopharmaceuticals including Pluvicto (Lutetium-177 PSMA) and Xofigo (Radium-223). She delivers Radioligand Therapy within urology clinics, offering targeted cancer care where patients are already receiving trusted support.
Certified Positions
Dr. Cook holds active medical licenses in multiple U.S. states, enabling her to travel and contract with urology providers nationwide. Her consulting and treatment services bring cutting-edge therapies directly to your patients.
Licensed in Several States
With over two decades of clinical experience, Dr. Cook serves as both an Authorized User (AU) and Radiation Safety Officer (RSO). She ensures regulatory compliance and patient safety while providing targeted radiation therapy with precision and care.
About
Dr. Cook
Dr. Cook is a board-certified Nuclear Medicine physician with over 23 years of clinical experience. As founder of Nuclear Therapeutics, she brings precision oncology to the frontlines of urology care. She meet with patients and provides state of the art radioligand therapy for them within their own Urologist’s office, allowing comfort and a continuity of care for each individual.
Contact Us
Interested in working with Dr. Cook or have questions about Nuclear Therapeutics?
Please fill out the form below and we’ll be in touch shortly.
Are you a patient? Please contact your urology provider.